GANX - Gain Therapeutics GAAP EPS of -$0.28 beats by $0.09 revenue of $0.05M beats by $0.01M May, 16 2022 04:46 PM Gain Therapeutics Inc. Gain Therapeutics press release (NASDAQ:GANX): Q1 GAAP EPS of -$0.28 beats by $0.09. Revenue of $0.05M (-99.1% Y/Y) beats by $0.01M. For further details see: Gain Therapeutics GAAP EPS of -$0.28 beats by $0.09, revenue of $0.05M beats by $0.01M